One of the finalists in the Massachusetts eHealth Institute’s (MeHI) Healthy Aging Challenge and a recipient of MeHI’s Sandbox Rolling Grant recently closed a €5.9 million funding round.
Massachusetts eHealth Institute (MeHI) grantee Onward Health, one of the winners of the Mass Digital Health Healthy Aging Challenge, recently expanded its service area from the San Francisco Bay Area to Southern California and Arizona. After launching in the San Francisco Bay Area, the expansion broadens access to Companion Rides, Onward’s assisted Door-Through-Door transportation service, to these two new markets.
Massachusetts eHealth Institute (MeHI) grantee Stellar Sleep, the winner of the 2022 COVID-19 Innovations to Support Healthcare Providers Challenge, recently announced that they raised $6 million in seed financing. Stellar Sleep’s solution is poised to transform sleep health for the 25 million Americans battling chronic insomnia, defined as having sleep problems three or more nights a week over the course of three or more months.
On June 15th, Boston-based myBiometry was the recipient of MeHI's $10,000 cash award for innovation at Boston Scientific's Connected Patient Challenge VII, administered by M2D2. myBiometry is a platform designed to remotely monitor and manage patients with asthma using software and biomarker data generated from proprietary sensors.
Leuko is developing the world’s first portable, non-invasive white blood cell monitoring device to screen for severe neutropenia. In May 2020 MeHI awarded $60,000 to Leuko to work with the MIT Center for Clinical and Translational Research (CCTR) to test and validate their solution. The grant enabled Leuko to test their PointCheck™ device with untrained operators in a simulated home environment, helping to prepare them for a clinical trial and FDA certification. We spoke with Ganimete Lamaj, Leuko’s Human Factors Engineer, to learn more.
In 2015, a three person team at Boston Children’s Hospital set out to help the estimated 20 percent of children struggling with emotional regulation, which often shows up as anxiety or outbursts. That team grew into a stand-alone company called Mightier, a startup that produces modified video games that help children develop skills to regulate their behavior and emotions.
We recently sat down with Trevor Stricker, one of the founding members of Mightier, to get a better understanding of their product and how it could change our approach to behavioral health. During the interview, Stricker noted how Massachusetts played a unique role in forming their company.
During his 30 years in the aging and caregiving space, Benchmark Chairman and CEO Tom Grape has seen a fair amount of change in the industry. Today, Benchmark operates nearly 60 different properties for seniors with four areas of focus: independent living, assisted living, mind and memory care, and continuing care retirement communities. While Grape manages a growing portfolio, he is always on the lookout for innovative products and solutions to implement at Benchmark.
Leuko co-founder, Carlos Castro-Gonzalez, was inspired to develop the technology with his partners at MIT after watching a friend go through treatment for non-Hodgkin's lymphoma. A typical chemotherapy cycle usually lasts about three weeks, resulting in a rise and fall of white blood cell levels after each treatment. The problem, as Castro-Gonzalez points out, is that current treatment methods only measure white blood cell counts before a new round of chemotherapy, leaving patients and providers in the dark about white blood cell counts after treatment. PointCheck fills that gap by allowing providers to see if a patient’s white blood cell count is at a healthy threshold at any time and determining how, if at all, they should change their treatment plan.
